Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by porksnifferon Feb 04, 2019 1:57pm

82 Views

Post# 29315944

RE:Porksniffer is Shorters lap dog

sanspeine wrote: Check out his posts.
Bashing is his job.

Clearly he is NOT a shareholder here.
So why is he posting here?
LOL
Put him on Ignore

Really? I'm not a shareholder? lol you have a lot of nerve. Here you go, straight out of my account. You can shut up now. I'm another one of the devoted longs taking it on the chin here, there are many others on here too. Feel free to leave now.

User image